Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner.
Kamal N, Holodinsky JK, Stephenson C, Kashayp D, Demchuk AM, Hill MD, Vilneff RL, Bugbee E, Zerna C, Newcommon N, Lang E, Knox D, Smith EE. Kamal N, et al. Among authors: stephenson c. Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1):e003242. doi: 10.1161/CIRCOUTCOMES.116.003242. Circ Cardiovasc Qual Outcomes. 2017. PMID: 28096208
Reliability of point-of-care testing of INR in acute stroke.
Green TL, Mansoor A, Newcommon N, Stephenson C, Stewart E, Hill MD. Green TL, et al. Among authors: stephenson c. Can J Neurol Sci. 2008 Jul;35(3):348-51. doi: 10.1017/s0317167100008945. Can J Neurol Sci. 2008. PMID: 18714804
Visualizing Acute Stroke Data to Improve Clinical Outcomes.
Kamal N, Smith EE, Stephenson C, Choi PM, Goyal M, Hill MD. Kamal N, et al. Among authors: stephenson c. Stroke. 2015 Jul;46(7):e170-2. doi: 10.1161/STROKEAHA.115.009517. Epub 2015 May 14. Stroke. 2015. PMID: 25977278 No abstract available.
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
Menon BK, Buck BH, Singh N, Deschaintre Y, Almekhlafi MA, Coutts SB, Thirunavukkarasu S, Khosravani H, Appireddy R, Moreau F, Gubitz G, Tkach A, Catanese L, Dowlatshahi D, Medvedev G, Mandzia J, Pikula A, Shankar J, Williams H, Field TS, Manosalva A, Siddiqui M, Zafar A, Imoukhuede O, Hunter G, Demchuk AM, Mishra S, Gioia LC, Jalini S, Cayer C, Phillips S, Elamin E, Shoamanesh A, Subramaniam S, Kate M, Jacquin G, Camden MC, Benali F, Alhabli I, Bala F, Horn M, Stotts G, Hill MD, Gladstone DJ, Poppe A, Sehgal A, Zhang Q, Lethebe BC, Doram C, Ademola A, Shamy M, Kenney C, Sajobi TT, Swartz RH; AcT Trial Investigators. Menon BK, et al. Lancet. 2022 Jul 16;400(10347):161-169. doi: 10.1016/S0140-6736(22)01054-6. Epub 2022 Jun 29. Lancet. 2022. PMID: 35779553 Clinical Trial.
495 results